Yahoo Sports' Pete Thamel talks with Alambama Head Coach Nate Oats after the Crimson Tide secure a No. 2 seed in the 2021 NCAA Basktball Tournament
Yahoo Sports' Pete Thamel talks with Alambama Head Coach Nate Oats after the Crimson Tide secure a No. 2 seed in the 2021 NCAA Basktball Tournament
MADRID — Most political parties in Spain put aside their differences Friday to condemn a series of death threats mailed to the country's interior minister, the director of the Civil Guard police force and the leader of a far-left political party. But the issue provoked a bitter confrontation between United We Can leader Pablo Iglesias, the recipient of one of the letters, and the far-right candidate in an upcoming regional election in Madrid, who cast doubts on the threats. Vox Party Madrid leader Rocío Monasterio said she was against “all kinds of violence” but, during a radio debate with Iglesias, refused to back away from earlier remarks that she didn't believe her opponent's account. As a result, three left-wing candidates refused to continue talking with the far-right politician and the debate ended abruptly. The threats were delivered in envelopes filled with bullets and accompanied by anonymous letters either demanding the three officials step down from their positions or plainly menacing the recipients and their relatives. Iglesias, who recently stepped down as one of Spain's four deputy prime ministers to run in the May 4 Madrid election, posted a photo on Twitter showing the four bullets he said arrived inside the envelope and the letter addressed to him at the Interior Ministry's headquarters in Madrid. “You have let die our parents and grandparents,” the letter posted by Iglesias read, adding: “Your wife, your parents and you are sentenced to capital punishment. Your time is running out.” Interior Minister Fernando Grande-Marlaska and his appointee, Civil Guard Director General María Gámez, received similar letters. “You have 10 days to step down. The time to laugh at us has ended. National Police. Civil Guard," read the letter addressed to Grande-Marlaska, according to the private news agency Europa Press. The interior minister oversees both police bodies. Monasterio had said that she didn't believe the Spanish government or Iglesias. “They have tricked us since the beginning of the pandemic,” she said during an interview. The far-left candidate said that he refused to whitewash the far-right's hate speech and left a debate hosted by Cadena SER radio later in the day when Monasterio refused to back away from her remarks. Iglesias was followed by two more left-wing candidates, leading the show's host to close the debate. The incumbent conservative Madrid president, Isabel Díaz Ayuso, is set to win next week's election according to the latest polls. But her ability to form a government is likely to hinge on opening the door to Spain's first regional coalition government with the far-right. Aritz Parra, The Associated Press
ANNUAL GENERAL SHAREHOLDERS’ MEETING OF NATUZZI S.P.A.
Judges quash convictions of 39 former postmasters after the UK's most widespread miscarriage of justice.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "5G Chipset Market by Type, Nanometer Size, Technology Integration and Use Cases 2021 - 2028" report has been added to ResearchAndMarkets.com's offering. Due to many factors, chipsets designed for 5G systems have unique factors including the need for optimal energy efficiency. The network effect is clearly evident as the impact of increasingly interconnected IoT systems will cause an acceleration in overall demand for chipsets due to the interdependency of platforms, equipment, and devices. Chipset technology is evolving with many vendors aggressively working towards improving data processing capability as well as energy efficiency and other key factors. In particular, AI chipset-enabled networks of devices and systems will drive substantial change in industrial and workplace environments. It is predicted that nearly 72% of the enterprises will be deploying AI solutions within the enterprise physical facility or application system by 2025. Chipsets will track user location, choice and preference, surrounding environment, machine behavior, and many other data patterns to generate actionable insights and tailored recommendations for each customer. Many important functions, such as connect, collect, and compute, will be powered by the performance of AI chipsets. AI chipsets provide the ability of learning from both users and the environment without the need to utilize explicitly programmed algorithms. AI chipsets are able to detect hidden patterns in new data and perform actions with customized approaches based on specific situations. AI chipsets will allow devices and systems to better understand the surrounding environment and user preferences to optimally execute specific functions. Chipset usage was up substantially during the first quarter of 2021. The industry as a whole is still struggling to rebuild supply in the wake of COVID-19 production shut-downs one year ago. A lack of supply could not have happened at a worse time as 5G is deploying worldwide, especially in the developed nations. However, we see several key companies ramping up production capabilities to meet market needs. This report evaluates the chipset market with an emphasis on the outlook for 5G chipsets. The report analyzes leading chipset vendors, strategies, and offerings. It also provides forecasts for the 5G chipset market by type, chipset size, frequency, technology integration and use cases from 2021 to 2028. Key Topics Covered: 1.0 Executive Summary 2.0 Introduction2.1 Connected Devices2.2 Data Access, Usage, and Chipsets2.3 Chipset Developments2.4 IoT Impact on Wireless and Chipsets2.4.1 Consumer IoT Devices2.4.2 Enterprise IoT Devices2.4.3 Industrial IoT Devices 3.0 Recent Developments in the 5G Chipset Market3.1 Qualcomm3.2 Samsung and Marvell3.3 Gogo3.4 Samsung Galaxy S20 FE 5G3.5 Vivo 4.0 5G Chipset Company Analysis4.1 Analog Devices Inc.4.2 Anokiwave Inc.4.3 Broadcom Inc.4.4 Cavium Inc.4.5 Huawei Technologies Co. Ltd.4.6 Infineon Technologies AG4.7 Intel Corporation4.8 Marvell Technology4.9 MediaTek Inc.4.10 Nokia Corporation4.11 NXP Semiconductors NV4.12 Qorvo Inc.4.13 Qualcomm Incorporated4.14 Renesas Electronics Corporation4.15 Samsung Electronics Co., Ltd.4.16 Texas Instruments Inc.4.17 U-Blox4.18 Unisoc Communications, Inc.4.19 Xilinx Inc. 5.0 Global 5G Chipset Market 2021 - 20285.1 Global 5G Chipset Market by Type 2021 - 20285.1.1 Global 5G Chipset Market by Chipset Use Case 2021 - 20285.1.2 Global 5G Chipset Market by RFIC Type 2021 - 202126.96.36.199 Global 5G Chipset Market by Rf Fe Type 2021 - 20285.2 Global 5G Chipset Market by Application 2021 - 20285.2.1 Global 5G Chipset Market by RAN Infrastructure 2021 - 20285.2.2 Global 5G Chipset Market by Mobile Device Application 2021 - 20285.2.3 Global 5G Chipset Market by Non-Mobile Device Application 2021 - 20285.2.4 Global 5G Chipset Market by Automotive Application 2021 - 20285.3 Global 5G Chipset Market by Frequency 2021 - 20285.4 Global 5G Chipset Market by Nanometer Size 2021 - 20285.5 Global AI Equipped 5G Chipset Market 2021 - 20285.5.1 Total AI Equipped 5G Chipset Market 2021 - 20285.5.2 Global AI Equipped 5G Chipset Market by Technology Type 2021 - 20285.6 Global 5G Chipset Market by Region 2021 - 2028 For more information about this report visit https://www.researchandmarkets.com/r/c8zgja About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B01FLG62 Issuer Name G4S PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name HSBC Holdings plc City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Is the shareholder the same as the person subject to the notification obligation, above? No Name City of registered office Country of registered office HSBC Bank plc London United Kingdom 5. Date on which the threshold was crossed or reached 20-Apr-2021 6. Date on which Issuer notified 22-Apr-2021 7. Total positions of person(s) subject to the notification obligation .% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer Resulting situation on the date on which threshold was crossed or reached 0.024000 0.000000 0.024000 375553 Position of previous notification (if applicable) 5.954000 0.001000 5.955000 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1) GB00B01FLG62 375553 0.024000 Sub Total 8.A 375553 0.024000% 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights Sub Total 8.B1 8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b)) Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights Sub Total 8.B2 9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary) Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold HSBC Holdings Plc HSBC Bank Plc 0.024000 0.024000 10. In case of proxy voting Is there proxy voting? No Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional Information 12. Date of Completion 22-Apr-2021 13. Place Of Completion London, United Kingdom
The cyber security sector has enjoyed strong growth in the past several years. Cyber security breaches ...
LONDON — Britain has seen its budget deficit rise during the coronavirus pandemic to its highest level since the year after the end of World War II, official figures showed Friday. The Office for National Statistics said public sector net borrowing — the official gauge of the difference between the government's spending and taxes — reached 303.1 billion pounds ($420 billion) in the financial year to end-March. This was equivalent to 14.5% of the country’s annual gross domestic product, the highest level since 1946, when the deficit hit 15.2% of GDP. The causes of the spike are simple. While tax receipts have ebbed as a result of the deepest recession in more than 300 years, the government has splashed out billions of pounds trying to prop up the economy and jobs since the pandemic first struck more than a year ago. Notably, it has been covering the lion's share of the salaries of people unable to work during the country's many lockdowns and providing further support to hard-hit businesses. The scale of the borrowing the government has undertaken in the wake of the pandemic is evident in the size of the increase in the deficit from 57 billion pounds in the previous financial year. “The increase on the pre-pandemic forecast is unprecedented and highlights the extraordinary impact of the pandemic on government revenues and spending,” said Isabel Stockton, research Economist at the well-respected Institute for Fiscal Studies. Stockton thinks the actual deficit will end up being higher, “perhaps quite significantly,” as many businesses won't be able to repay government-backed loans. In the post-war era the deficit peaked in the aftermath of the 2008 financial crisis, hitting around 10% of GDP. The average deficit since 1970 has been 3.4% of GDP. The borrowing undertaken by the government has pushed public sector net debt up to 2,142 billion pounds, which is 97.7% of Britain's GDP. This is the highest proportion since the early 1960s. Because interest rates are low historically, the government doesn't have much of a problem managing its debt, but economists worry that higher borrowing rates in coming years may create problems in the future. The government is hoping that the economy, which shrank by nearly 10% during 2020, will recover strongly through the spring and summer as lockdown restrictions are eased in the wake of the sharp fall in coronavirus cases, and amid the rapid rollout of vaccines. ___ Follow AP’s pandemic coverage at: https://apnews.com/hub/coronavirus-pandemic https://apnews.com/hub/coronavirus-vaccine https://apnews.com/UnderstandingtheOutbreak Pan Pylas, The Associated Press
Holden's stylish ensembles are more affordable than you might think.
Some of Wall Street's biggest names are predicting a pause in a rally that has taken the S&P 500 to fresh records this year, leaving investors trying to determine whether to lock in some of the breathtaking gains or stay the course. Among the most recent has been Goldman Sachs, whose analysts on Wednesday said an expected second-quarter peak in U.S. growth could be tied to weaker stock returns. Morgan Stanley earlier this week warned stocks would soon face headwinds.
"They spent planning this league for years, and in a span of 48 hours, it has dissolved like a lump of sugar. The Super League is gone. If it was so good for football, they wouldn’t have done it behind our backs," LaLiga boss Javier Tebas said.
Advisers to the U.S. Centers for Disease Control and Prevention will meet again on Friday to consider whether to it is safe to resume injections of Johnson & Johnson's COVID-19 vaccine, as senior U.S. health officials prepare for a green light. The panel last week called for more data about a possible link to rare blood clots in the brain before deciding how and whether to end a "pause" in administration of J&J vaccines called for by the CDC and the Food and Drug Administration. The decision by CDC's advisory panel has global implications since J&J's immunization is seen as an important tool for poorer countries and less accessible populations, given that it only requires one dose and can be stored at normal refrigerator temperatures, making it relatively easy to transport.
Hailey Watts, 18, was shot Tuesday as an assailant fired upon someone else, police said.
Japanese brand ANAORI, a leader in manufacturing carbon graphite products, has developed a groundbreaking cooking tool that combines new technologies and natural materials in a unique design. In the coming weeks, renowned chefs from around the world will apply their expertise to showcase the potential of ANAORI kakugama.
Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc. , Baxter International, BD. , Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc. , Bayer AG, and GlaxoSmithKline plc.New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Drug Delivery Devices Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06065176/?utm_source=GNW The global drug delivery devices market is expected to grow from $40.7 billion in 2020 to $42.76 billion in 2021 at a compound annual growth rate (CAGR) of 5.1%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $50.9 billion in 2025 at a CAGR of 4.5%.The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases.The market includes the sales of the devices that are specifically made for delivering the specific drugs according to the various administration techniques such as oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery.Drug delivery devices used in various patient care settings such as hospitals, diagnostic centres, pharmaceutical companies, clinics and home care settings are included in this market.owing to the Covid-19 pandemic. Drugs used for Covid-19 treatment are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices.The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market.The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line.Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework.Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, penalties at a global level.For instance, European Union (EU) and the parliament in 2017 approved the new Medical Device Regulation (MDR) and Medical Device Single Audit Program (MDSAP) to monitor all the medical devices for quality.The new MDSAP will come into effect from 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia.Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety.The major players operating in the global microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nano Biosciences LLC, Nano Pass and more.The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles.Once, the microneedles dissolve in the skin, the drug gets released.This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies.For example, in December 2019, Leo Pharma, a Danish pharmaceutical company, has collaborated with Portal Instruments to build Portal’s advanced needle-free drug delivery system for use in conjunction with LEO Pharma’s research and approved drug portfolio.This simplifies administration and removes the need for sharp containers at home, and also decreases the time required for self-injections.In August 2020, Sulzer, a Swiss-based engineering and manufacturing firm acquired Haselmeier GmbH for $118m.The acquisition of Haselmeier will allow Sulzer to complement its healthcare portfolio, in addition to leveraging its APS expertise in precision injection moulding to expand its presence in the drug delivery devices market.Haselmeier GmbH, a Swiss-German drug delivery device developer and manufacturer.The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market.According to the world health organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.There are various routes of drug administration for medical drugs.The selection of the route depends on three factors - the effect desired; the type of the disease and the type of the product.Currently, the development of new drug delivery systems plays a major role in pharmaceutical industries.Research and development (R&D) in drug delivery are increasing throughout the world due to increasing prevalence of these diseases.Most of the pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcome for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.Read the full report: https://www.reportlinker.com/p06065176/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) ("Avivagen"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general health and performance, is pleased to announce it has received a purchase order for a single shipment of 4.4 metric tonnes of OxC-beta™ Livestock from UNAHCO. The purchase order is the largest single shipment purchase order of OxC-beta™ to date and represents a 10% increase in size over its previous record single shipment order.
Restaurant Brands International Inc. (TSX: QSR) (NYSE: QSR) (TSX: QSP) will release its first quarter 2021 financial results on Friday, April 30, 2021 and will host an investor conference call that morning at 8:30 a.m. Eastern Time.
You can always expect tree trunks to show up for the big spring dance with a variety of issues.
The Gorman-Rupp Company (NYSE: GRC) announced today that at the Annual Meeting of the Shareholders of The Gorman-Rupp Company held on April 22, 2021, Scott A. King was elected to the Board of Directors.
“I’m tired of talking to my son about this. Like, I shouldn’t have to explain it to a 14-year-old so many times that he’s looking at me like, ‘I know, I know,’” one Durham man said. And he’s not alone.
Four astronauts vaulted off the pad at the Kennedy Space Center early Friday, kicking off NASA and SpaceX's second full-duration mission to the ISS.